Samidorphan Impurity 3
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

421552-35-4Samidorphan Impurity 3

● In Stock

Catalogue No.:VE0023588
CAS No.:421552-35-4
Mol. Formula:C21H24N2O4
Mol. Weight:368.4 g/mol

Additional information on CAS 421552-35-4

Parent drug

Samidorphan

IUPAC Name

(4R, 4aS, 7aR, 12bS)-3-(cyclopropylmethyl)-4a-hydroxy-7-oxo-2, 3, 4, 4a, 5, 6, 7, 7a-octahydro-1H-4, 12-methanobenzofuro[3, 2-e]isoquinoline-9-carboxamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

3-desoxy-3-carboxamidonaltrexone ;3-Carboxamidonaltrexone

Smiles

O=C(C1=C2C([C@]3([C@@]4([H])O2)CCN(CC5CC5)[C@@](C6)([H])[C@]3(O)CCC4=O)=C6C=C1)N

InChI

InChI=1S/C21H24N2O4/c22-19(25)13-4-3-12-9-15-21(26)6-5-14(24)18-20(21, 16(12)17(13)27-18)7-8-23(15)10-11-1-2-11/h3-4, 11, 15, 18, 26H, 1-2, 5-10H2, (H2, 22, 25)/t15-, 18+, 20+, 21-/m1/s1

Description

Samidorphan Impurity 3 is a well-characterized reference material that meets stringent regulatory standards set by USP | EMA | JP | and BP. It plays a key role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Samidorphan. To ensure accuracy and reliability across various analytical applications | it includes a comprehensive Structure Elucidation Report (SER) | providing valuable insights for quality control and method development.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url